En tilstrækkelig dosering, der sikrer optimal klinisk virkning og forhindrer resistensdannelse, er derfor vigtig både for den enkelte patient og for samfundet, navnlig i lyset af den stigende forekomst af resistente uropatogener.
An adequate dosing, in order to achieve optimal clinical efficacy and to prevent emergence of antimicrobial resistance, is therefore crucial both for the individual patient and for the society, especially in light of the current increase of resistant uropathogens.